EPAS1 and pulmonary arterial hypertension: The PBMC based gene set score heat map of the 13 overlapped GO terms reveals a clear separation between controls and PAH patients (Figure 3B), which suggests that the differences exist in PBMC expression of the HIF2α-mediated gene sets can be used as a biomarker of PAH to identify high-risk population and promote early diagnosis.